
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Lipopolysaccharide-Mediated Chronic Inflammation Promotes Tobacco Carcinogen–Induced Lung Cancer and Determines the Efficacy of Immunotherapy
Chia‐Hsin Liu, Zhong Chen, Kong Chen, et al.
Cancer Research (2020) Vol. 81, Iss. 1, pp. 144-157
Open Access | Times Cited: 79
Chia‐Hsin Liu, Zhong Chen, Kong Chen, et al.
Cancer Research (2020) Vol. 81, Iss. 1, pp. 144-157
Open Access | Times Cited: 79
Showing 1-25 of 79 citing articles:
Epidemiology of Glioblastoma Multiforme–Literature Review
Szymon Grochans, Anna Maria Cybulska, Donata Simińska, et al.
Cancers (2022) Vol. 14, Iss. 10, pp. 2412-2412
Open Access | Times Cited: 338
Szymon Grochans, Anna Maria Cybulska, Donata Simińska, et al.
Cancers (2022) Vol. 14, Iss. 10, pp. 2412-2412
Open Access | Times Cited: 338
Antioxidant, Anti-Inflammatory, Anti-Menopausal, and Anti-Cancer Effects of Lignans and Their Metabolites
Won Young Jang, Mi‐Yeon Kim, Jae Youl Cho
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15482-15482
Open Access | Times Cited: 87
Won Young Jang, Mi‐Yeon Kim, Jae Youl Cho
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15482-15482
Open Access | Times Cited: 87
Non-coding RNAs in lung cancer: molecular mechanisms and clinical applications
Ying Liu, Wei‐Qun Ding, Jianxun Wang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 44
Ying Liu, Wei‐Qun Ding, Jianxun Wang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 44
Systemic immune-inflammation index predicts prognosis and responsiveness to immunotherapy in cancer patients: a systematic review and meta‑analysis
Junyan Kou, Jing Huang, Jun Li, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 7, pp. 3895-3905
Closed Access | Times Cited: 25
Junyan Kou, Jing Huang, Jun Li, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 7, pp. 3895-3905
Closed Access | Times Cited: 25
T cell exhaustion in human cancers
Kuan Kang, Xin Lin, Pan Chen, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189162-189162
Closed Access | Times Cited: 8
Kuan Kang, Xin Lin, Pan Chen, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189162-189162
Closed Access | Times Cited: 8
Risk factors for immune checkpoint inhibitor-related pneumonitis in non-small cell lung cancer
Yencheng Chao, Jiebai Zhou, Shu-Jung Hsu, et al.
Translational Lung Cancer Research (2022) Vol. 11, Iss. 2, pp. 295-306
Open Access | Times Cited: 31
Yencheng Chao, Jiebai Zhou, Shu-Jung Hsu, et al.
Translational Lung Cancer Research (2022) Vol. 11, Iss. 2, pp. 295-306
Open Access | Times Cited: 31
Regulatory network and targeted interventions for CCDC family in tumor pathogenesis
Zhen Liu, Weiwei Yan, Shaohua Liu, et al.
Cancer Letters (2023) Vol. 565, pp. 216225-216225
Closed Access | Times Cited: 20
Zhen Liu, Weiwei Yan, Shaohua Liu, et al.
Cancer Letters (2023) Vol. 565, pp. 216225-216225
Closed Access | Times Cited: 20
Examining the Mechanisms behind Exercise’s Multifaceted Impacts on Body Composition, Cognition, and the Gut Microbiome in Cancer Survivors: Exploring the Links to Oxidative Stress and Inflammation
Benjamin Matei, Kerri M. Winters‐Stone, Jacob Raber
Antioxidants (2023) Vol. 12, Iss. 7, pp. 1423-1423
Open Access | Times Cited: 17
Benjamin Matei, Kerri M. Winters‐Stone, Jacob Raber
Antioxidants (2023) Vol. 12, Iss. 7, pp. 1423-1423
Open Access | Times Cited: 17
NLRP3 and cancer: Pathogenesis and therapeutic opportunities
Isak W. Tengesdal, Charles A. Dinarello, Carlo Marchetti
Pharmacology & Therapeutics (2023) Vol. 251, pp. 108545-108545
Closed Access | Times Cited: 17
Isak W. Tengesdal, Charles A. Dinarello, Carlo Marchetti
Pharmacology & Therapeutics (2023) Vol. 251, pp. 108545-108545
Closed Access | Times Cited: 17
The microbiome: a link between obesity and breast cancer risk
Mohamed Gaber, Alana A. Arnone, Pierre‐Alexandre Vidi, et al.
Frontiers in Microbiomes (2024) Vol. 3
Open Access | Times Cited: 7
Mohamed Gaber, Alana A. Arnone, Pierre‐Alexandre Vidi, et al.
Frontiers in Microbiomes (2024) Vol. 3
Open Access | Times Cited: 7
Microbial metabolites affect tumor progression, immunity and therapy prediction by reshaping the tumor microenvironment (Review)
Yuhang Zhou, Wenjie Han, Yun Feng, et al.
International Journal of Oncology (2024) Vol. 65, Iss. 1
Open Access | Times Cited: 6
Yuhang Zhou, Wenjie Han, Yun Feng, et al.
International Journal of Oncology (2024) Vol. 65, Iss. 1
Open Access | Times Cited: 6
Chitosan oligosaccharide regulates AMPK and STAT1 pathways synergistically to mediate PD-L1 expression for cancer chemoimmunotherapy
Jiashe Chen, Zaigang Zhou, Chunjuan Zheng, et al.
Carbohydrate Polymers (2021) Vol. 277, pp. 118869-118869
Closed Access | Times Cited: 37
Jiashe Chen, Zaigang Zhou, Chunjuan Zheng, et al.
Carbohydrate Polymers (2021) Vol. 277, pp. 118869-118869
Closed Access | Times Cited: 37
Nicotine promotes chronic obstructive pulmonary disease via inducing pyroptosis activation in bronchial epithelial cells
Rubing Mo, Jun Zhang, Chuming Chen, et al.
Molecular Medicine Reports (2022) Vol. 25, Iss. 3
Open Access | Times Cited: 24
Rubing Mo, Jun Zhang, Chuming Chen, et al.
Molecular Medicine Reports (2022) Vol. 25, Iss. 3
Open Access | Times Cited: 24
Similar programmed death ligand 1 (PD-L1) expression profile in patients with mild COPD and lung cancer
Francesca Polverino, Davida Mirra, Chen Xi Yang, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 20
Francesca Polverino, Davida Mirra, Chen Xi Yang, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 20
Diet-gut microbial interactions influence cancer immunotherapy
Xue Wang, Shi-Tao Geng
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 11
Xue Wang, Shi-Tao Geng
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 11
Therapeutic Effects of Lifei Decoction in a Murine Model of COPD Induced by LPS and Cigarette Smoke
Liguo Lu, Chengdong Zhu, Jian Xu, et al.
International Journal of COPD (2024) Vol. Volume 19, pp. 957-967
Open Access | Times Cited: 4
Liguo Lu, Chengdong Zhu, Jian Xu, et al.
International Journal of COPD (2024) Vol. Volume 19, pp. 957-967
Open Access | Times Cited: 4
Injectable hydrogel-assisted local lipopolysaccharide delivery improves immune checkpoint blockade therapy
Jiaxuan Li, Kuirong Mao, Xiandi Meng, et al.
Acta Biomaterialia (2025)
Closed Access
Jiaxuan Li, Kuirong Mao, Xiandi Meng, et al.
Acta Biomaterialia (2025)
Closed Access
m7G-related gene NUDT4 as a novel biomarker promoting cancer cell proliferation in lung adenocarcinoma
Yafei Liu, Bin Jiang, Chunjie Lin, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 10
Yafei Liu, Bin Jiang, Chunjie Lin, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 10
Evaluating the predictive significance of systemic immune-inflammatory index and tumor markers in lung cancer patients with bone metastases
Jinxian He, Gaofeng Liang, Hongyan Yu, et al.
Frontiers in Oncology (2024) Vol. 13
Open Access | Times Cited: 3
Jinxian He, Gaofeng Liang, Hongyan Yu, et al.
Frontiers in Oncology (2024) Vol. 13
Open Access | Times Cited: 3
A Systemic Immune Inflammation Index and PD-L1 (SP142) Expression as a Potential Combined Biomarker of the Clinical Benefit of Chemo-Immunotherapy in Extensive-Stage Small-Cell Lung Cancer
Jong Min Baek, Hyungkeun Cha, Yeonsook Moon, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 5, pp. 1521-1521
Open Access | Times Cited: 3
Jong Min Baek, Hyungkeun Cha, Yeonsook Moon, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 5, pp. 1521-1521
Open Access | Times Cited: 3
Biomarkers of Immunotherapy Response in Patients with Non-Small-Cell Lung Cancer: Microbiota Composition, Short-Chain Fatty Acids, and Intestinal Permeability
Alba Moratiel Pellitero, María Zapata-García, Marta Gascón Ruiz, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1144-1144
Open Access | Times Cited: 3
Alba Moratiel Pellitero, María Zapata-García, Marta Gascón Ruiz, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1144-1144
Open Access | Times Cited: 3
Analysis and prediction of immune cell infiltration characteristics in COPD: Folium isatidis and its active ingredients are able to combat lung lesions caused by COPD by correcting immune cell infiltration
Fei Wang, Weichen Zhang, Yujie Huang, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Fei Wang, Weichen Zhang, Yujie Huang, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Xin Chen, Weifan Zhang, Ru‐Juan Liu, et al.
Molecular Oncology (2022) Vol. 16, Iss. 15, pp. 2881-2895
Open Access | Times Cited: 16
Bacterial DNA involvement in carcinogenesis
Wang Yangyanqiu, Han Shuwen
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 15
Wang Yangyanqiu, Han Shuwen
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 15
Cytoplasmic DNAs: Sources, sensing, and roles in the development of lung inflammatory diseases and cancer
Xintong He, Ye Sun, Jianzhang Lu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Xintong He, Ye Sun, Jianzhang Lu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8